Ultime notizie per CYREN (OTC:CYRNQ) Azioni

CYREN Ltd is a provider of cloud-delivered Software-as-a-Service (SaaS) cybersecurity solutions that protect businesses. Its cloud security products and services fall into the categories of Cyren Threat Detection Services; Cyren Threat Intelligence Data and Cyren Enterprise Email Security Products. It derives revenues from the sale of real-time cloud-based services for each of the company's email security, web security, anti-malware, and advanced threat protection offerings. The group has a business presence in Israel, the United States, Germany and other countries, of which prime revenue is derived from Israel. The company's offerings include Email Security Detection Engine, Malware Detection Engine, Web Security Engine, Phishing Intelligence, Malware Intelligence and other services.

CYREN Ltd

Entry into Non-Binding Letter of Intent
Marin Software Incorporated (the "Company") has entered into a non-binding letter of intent (the "LOI") with a private equity firm (the "Counterparty") to explore a potential transaction whereby the Counterparty would acquire substantially all of the assets of the Company, which may be through a voluntary reorganization transaction (the "Potential Transaction"). The Company's Board of Directors (the "Board") believes that the Potential Transaction, if consummated on the terms set forth in the LOI, will result in greater liquidating distributions to the Company's stockholders than the currently contemplated voluntary dissolution of the Company (the "Dissolution"), as described in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission (the "SEC") on May 7, 2025 (the "Proxy Statement") for a Special Meeting of Stockholders to occur on June 11, 2025 (the "Special Meeting").
Entry into Secured Promissory Note
On June 6, 2025, the Company issued a demand secured promissory note to an affiliate of the Counterparty (the "Promissory Note"), in the principal amount of $300,000, with the Company receiving gross proceeds of $300,000, to be used for the Company's legal and other expenses to pursue the Potential Transaction as contemplated by the LOI.
The Promissory Note is secured by the Company's intellectual property, bears interest at a rate of 10% per annum, and has a maturity date of August 5, 2025 (the "Maturity Date"). The outstanding principal amount and any unpaid accrued interest may be prepaid at any time, upon two business days' notice, without premium or penalty. The Promissory Note includes customary representations, warranties, and covenants and sets forth certain events of default after which the outstanding principal may be declared immediately due and payable in advance of the Maturity Date and an additional default interest rate of 3% per annum will accrue on the then-outstanding balance.
The Promissory Note shall be forgiven and the Company shall have no obligation to repay the Promissory Note in the event that (A) (i) the Company does not initiate certain steps related to the Proposed Transaction by June 30, 2025, provided that the Company uses commercially reasonable best efforts with respect thereto, or (ii) the Proposed Transaction is terminated by the Company and the Counterparty or by either of them, other than if the termination of the Proposed Transaction is (x) by the Counterparty (1) due to a material breach of the LOI or a definitive agreement for the Potential Transaction by the Company or (b) the Company's exercise of certain rights not to proceed with the Potential Transaction or (y) by the Company absent a material breach by the Counterparty of the LOI or a definitive agreement for the Potential Transaction; (B) the Counterparty elects not to proceed with the Proposed Transaction as a result of the Company's failure to achieve certain milestones; or (C) the Company and the Counterparty not reaching an agreement with respect to definitive agreements for the Potential Transaction following good faith negotiations.

News

Asset Sales

MRIN

Marin Software Enters Non-Binding LOI With Private Equity Firm For Potential Asset Sale Via Voluntary Reorganization Transaction

WIIM

CBRL

Cracker Barrel Old Country Store shares are trading lower after the company announced a proposed $275 million private offering of convertible senior notes due 2030.

Guidance

SKIL

Skillsoft Affirms FY2026 Sales Guidance of $530.00M-$545.00M vs $537.18M Est

CVGW

Calavo Growers shares are trading lower after the company reported worse-than-expected Q2 financial results.

Earnings

Earnings Beats

Skillsoft Q1 Adj. EPS $0.30 Beats $(2.65) Estimate, Sales $124.20M Beat $123.50M Estimate

Calavo Growers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGW#NASDAQ">CVGW</a>) reported quarterly earnings of $0.40 per share which missed the analyst consensus estimate of $0.53 by 24.53 percent. This is a 20 percent decrease over earnings of $0.50 per share from the same period last year. The company reported quarterly sales of $190.55 million which missed the analyst consensus estimate of $201.48 million by 5.43 percent. This is a 3.34 percent increase over sales of $184.38 million the same period last year.

Earnings Misses

Calavo Growers Q2 Adj. EPS $0.40 Misses $0.53 Estimate, Sales $190.55M Miss $201.48M Estimate

IonQ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>)&nbsp;shares traded higher Monday after the company announced results of a collaborative research program with AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>), Amazon Web Services and NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) to develop and demonstrate a quantum-accelerated computational chemistry workflow.
What To Know: IonQ said the partnership delivered over a 20x speed improvement compared to previous methods used in early-stage drug development research. The project integrated IonQ's quantum computing hardware with AWS and Nvidia platforms to reduce processing time from months to days.
The company said this marks its most complex demonstration to date and highlights the potential for quantum computing to accelerate pharmaceutical research.
"This demonstration with AstraZeneca represents a meaningful step toward practical quantum computing applications," said IonQ CEO Niccolo de Masi.
IONQ Price Action: IonQ stock closed Monday 2.67% higher at $40.06, according to data from <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/pro/&amp;ved=2ahUKEwj1irjk3-SNAxXGlIkEHS5zGGoQFnoECAsQAQ&amp;usg=AOvVaw0xIsPvjIcIIsWev01-6zR2">Benzinga Pro</a>.
See Also: • <a href="https://www.benzinga.com/trading-ideas/previews/25/06/45846835/gamestop-q1-earnings-preview-bitcoin-on-the-balance-sheet-but-dont-expect-much-detail">GameStop Q1 Earnings Preview: Bitcoin On The Balance Sheet, But Don&#8217;t Expect Much Detail</a>
Image via Shutterstock

Movers

Tech

IONQ

NVDA

What's Going On With IonQ Shares Monday?

LMNR

Limoneira Continues To Expect Avocado Volumes To Be In Range Of 7.0M - 8.0M Pounds For FY25

Xometry, Inc. ("Xometry") (XMTR), the global AI-powered marketplace connecting buyers with suppliers of manufacturing services, today announced its intent to offer, subject to market conditions and other factors, $225 million aggregate principal amount of Convertible Senior Notes due 2030 (the "Notes") in a private placement (the "Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Xometry also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $25 million aggregate principal amount of Notes.

Offerings

XMTR

Xometry Announces Its Intent To Offer $225M Aggregate Principal Amount Of Convertible Senior Notes Due 2030

Limoneira Now Expects Fresh Lemon Volumes To Be In Range Of 4.5M - 5.0M Cartons For FY25

LVLU

Lulu's Fashion Lounge Holdings Approves Equity Listing Transfer to Nasdaq Capital Market

Cracker Barrel Old Country Store, Inc. ("Cracker Barrel" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) today announced its intention to offer, subject to market conditions and other considerations, $275 million aggregate principal amount of convertible senior notes due 2030 (the "notes") in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Cracker Barrel also intends to grant the initial purchasers of the notes an option to purchase, for delivery within a period of 13 days from, and including, the date the notes are first issued, up to an additional $41.25 million aggregate principal amount of notes.

Cracker Barrel Announces Proposed $275 Million Private Offering Of Convertible Senior Notes Due 2030

Biotech

Events

General

MNKD

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin At American Diabetes Association's 85th Scientific Sessions

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.01) by 1600 percent. This is a 138.64 percent decrease over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $35.12 million which missed the analyst consensus estimate of $38.70 million by 9.25 percent. This is a 21.27 percent decrease over sales of $44.61 million the same period last year.

Limoneira Q2 Adj. EPS $(0.17) Misses $(0.01) Estimate, Sales $35.12M Miss $38.70M Estimate

LAKE

Lakeland Industries Affirms FY2026 Sales Guidance of $210.00M-$220.00M vs $211.10M Est

The New York Stock Exchange ("NYSE" or, the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Sunnova Energy International Inc. (the "Company") — ticker symbol NOVA — from the NYSE. Trading in the Company's common stock will be suspended immediately.
NYSE Regulation reached its decision that the Company is no longer suitable for listing pursuant to NYSE Listed Company Manual Section 802.01D after the Company's June 9, 2025 disclosure that on June 8, 2025, the Company, Sunnova Energy Corporation and Sunnova Intermediate Holdings, LLC each filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of Texas. In reaching its delisting determination, NYSE Regulation notes the uncertainty as to the ultimate effect of this process on the value of the Company's common stock.
The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company's common stock upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff's decision.

NOVA

NYSE To Commence Delisting Proceedings Against Sunnova Energy International Inc.

Lakeland Industries Q1 Adj. EPS $0.22 Beats $0.19 Estimate, Sales $46.75M Miss $48.85M Estimate

Merger positions Limoneira for anticipated growth in both food service and retail markets
Strategic partnership expected to generate $5 million in annual cost savings and EBITDA improvement beginning fiscal year 2026
Limoneira Company (the "Company" or "Limoneira") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, today announced a strategic merger of its citrus sales and marketing operations with Sunkist Growers, Inc. ("Sunkist"), creating a powerful platform to serve food service and retail sectors. Beginning in the first quarter of fiscal year 2026, Limoneira will return to Sunkist as one of their largest lemon growers and an exclusive Sunkist private licensed packer.
This strategic reunion is expected to generate $5 million in annual cost savings and EBITDA improvement starting in fiscal year 2026 through planned streamlined operations and enhanced supply chain efficiency. Under the new agreement, Limoneira's sales and marketing team will transition to Sunkist, creating operational synergies through shared storage, washing, and packing capabilities across the Sunkist network.

Limoneira Announces Strategic Merger Of Citrus Sales And Marketing Operations With Sunkist Growers; Strategic Reunion Expected To Generate $5M In Annual Cost Savings And EBITDA Improvement Starting In FY26

Leonardo DRS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRS#NASDAQ">DRS</a>) announced today that it has been awarded a $41 million contract from the Naval Sea Systems Command to continue delivering critical combat management system hardware for U.S. Navy surface combatants, allied naval forces, and the U.S. Coast Guard.
Under the contract, Leonardo DRS will provide a range of advanced hardware—including multi-screen consoles, displays, and peripheral equipment—designed to support the AEGIS Combat System and Ship Self-Defense System (SSDS) deployed on a variety of large and small deck ships.

Leonardo DRS Bags $41M Contract From Naval Sea Systems Command To Continue Delivering Critical Combat Management System Hardware For U.S. Navy Surface Combatants, Allied Naval Forces, And U.S. Coast Guard

- Composition of matter patent affirmed, provides protection into 2030
- Builds on recent ruling in favor of Acadia for formulation patent expiring in 2038
Acadia Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACAD#NASDAQ">ACAD</a>) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed a decision issued by the U.S. District Court for the District of Delaware in December 2023 confirming validity of the NUPLAZID&#xAE; (pimavanserin) '740 composition of matter patent. The affirmance came in Acadia's litigation against MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals, Inc.
In its affirmance, the Appeals Court applied the precedent established in Allergan USA, Inc. v. MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, holding that "a first filed, first-issued, later-expiring claim cannot be invalidated by a later-filed, later-issued, earlier-expiring reference claim having a common priority date."

Legal

ACAD

Acadia Wins Appeals Court Affirmation Of NUPLAZID Composition Of Matter Patent Valid Through 2030, Strengthening IP Protection Alongside Recent Formulation Patent Ruling Extending To 2038

CYREN

Comments

CYREN

Notizie

Ultime notizie per CYREN (OTC:CYRNQ) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO